Herceptin, Trastuzumab Newswire (Page 5)

Herceptin, Trastuzumab Newswire (Page 5)

Comprehensive Real-Time News Feed for Herceptin, Trastuzumab (generic). (Page 5)

Results 81 - 100 of 898 in Herceptin, Trastuzumab (generic)

  1. Sound sleep elusive for many kids with ADHDRead the original story w/Photo

    Jun 9, 2016 | CBS 3 Springfield

    Talking on a hands-free phone while driving may be just as distracting and dangerous as using a hand-held phone, according to a new study. Talking on a hands-free phone while driving may be just as distracting and dangerous as using a hand-held phone, according to a new study.

    Comment?

  2. Cutting back on wine? Try a smaller glassRead the original story w/Photo

    Jun 9, 2016 | CBS 3 Springfield

    Talking on a hands-free phone while driving may be just as distracting and dangerous as using a hand-held phone, according to a new study. Talking on a hands-free phone while driving may be just as distracting and dangerous as using a hand-held phone, according to a new study.

    Comment?

  3. Marriage a boost for heart attack survivorsRead the original story w/Photo

    Jun 9, 2016 | CBS 3 Springfield

    Married people are more likely to survive a heart attack and leave the hospital sooner than single people, a new British study finds. Married people are more likely to survive a heart attack and leave the hospital sooner than single people, a new British study finds.

    Comment?

  4. More Read the original story w/Photo

    Jun 9, 2016 | CBS 3 Springfield

    California on Thursday becomes the fifth and largest state in the country to allow terminally ill patients to end their own lives. California on Thursday becomes the fifth and largest state in the country to allow terminally ill patients to end their own lives.

    Comment?

  5. Mylan and Biocon Present Trastuzumab Biosimilar Data at ASCORead the original story w/Photo

    Jun 9, 2016 | JD Supra

    On June 3, Mylan N.V. and Biocon Ltd. presented phase 3 clinical data regarding their trastuzumab product , which is a proposed biosimilar to Genentech's Herceptin, at the 2016 American Society of Clinical Oncology Annual Meeting. Trastuzumab is indicated for the treatment of HER2-positive metastatic breast cancer patients, and for adjuvant treatment of HER2 overexpressing breast cancer and metastatic gastric cancer.

    Comment?

  6. Oncobiologics Inc (ONSIU) Coverage Initiated at Jefferies GroupRead the original story w/Photo

    Jun 9, 2016 | Daily Political

    The brokerage set a "buy" rating and a $7.00 price target on the stock. Jefferies Group's target price indicates a potential upside of 46.75% from the stock's previous close.

    Comment?

  7. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cellsRead the original story w/Photo

    Jun 8, 2016 | BioMed Central

    Resistance to taxane-based therapy in breast cancer patients is a major clinical problem that may be addressed through insight of the genomic alterations leading to taxane resistance in breast cancer cells. In the current study we used whole exome sequencing to discover somatic genomic alterations, evolving across evolutionary stages during the acquisition of docetaxel resistance in breast cancer cell lines.

    Comment?

  8. Does DNA determine success in life?Read the original story w/Photo

    Jun 8, 2016 | CBS 3 Springfield

    More American women than ever are obese, while the number of men carrying around far too many pounds has held steady, new research shows. Intensive treatment of blood sugar levels in some people with type 2 diabetes may cause serious complications, new research suggests.

    Comment?

  9. Obesity rates rising among womenRead the original story w/Photo

    Jun 8, 2016 | CBS 3 Springfield

    More American women than ever are obese, while the number of men carrying around far too many pounds has held steady, new research shows. More American women than ever are obese, while the number of men carrying around far too many pounds has held steady, new research shows.

    Comment?

  10. Intensive blood sugar control may be too much for some with type 2 diabetesRead the original story w/Photo

    Jun 8, 2016 | CBS 3 Springfield

    More American women than ever are obese, while the number of men carrying around far too many pounds has held steady, new research shows. More American women than ever are obese, while the number of men carrying around far too many pounds has held steady, new research shows.

    Comment?

  11. Mentally ill still gain illegal possession of gunsRead the original story w/Photo

    Jun 8, 2016 | CBS 3 Springfield

    Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals. Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals.

    Comment?

  12. Breast Cancer Drugs Market 2016-2026: Revenue Forecasts for...Read the original story w/Photo

    Jun 7, 2016 | PR Newswire

    Breast Cancer Therapies - Discover From 2016 What Revenues Are Possible Are you interested in the breast cancer drug market's future? If so, you find that sales forecasting from 2016 in our new report. See there what is possible for those products and companies.

    Comment?

  13. Cheaper breast cancer drug does well in clinical trialRead the original story w/Photo

    Jun 7, 2016 | KFVS12

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. HER2-positive tumors contain certain genes that are associated with more rapid tumor growth and a worse prognosis, according to the American Cancer Society.

    Comment?

  14. Drug duo cures a tick-borne disease -- in miceRead the original story w/Photo

    Jun 7, 2016 | CBS 3 Springfield

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. Certain vaccines can trigger fever-related seizures in young children, but the risk is so low that pediatricians might see one case every five to 10 years, a new study estimates.

    Comment?

  15. Childhood vaccinations rarely spur seizuresRead the original story w/Photo

    Jun 7, 2016 | CBS 3 Springfield

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds.

    Comment?

  16. Oncobiologics Inc (ONSIU) Coverage Initiated at BarclaysRead the original story w/Photo

    Jun 7, 2016 | AmericanBankingNews.com

    The firm set an "overweight" rating and a $11.00 price target on the stock. Barclays' price target would suggest a potential upside of 115.26% from the company's previous close.

    Comment?

  17. Oncobiologics Inc (ONSIU) Coverage Initiated at Cantor FitzgeraldRead the original story w/Photo

    Jun 7, 2016 | AmericanBankingNews.com

    The brokerage set a "buy" rating and a $15.00 price target on the stock. Cantor Fitzgerald's price target suggests a potential upside of 193.54% from the company's current price.

    Comment?

  18. Study identifies significant cost differences between breast cancer chemotherapy regimensRead the original story w/Photo

    Jun 4, 2016 | PhysOrg Weblog

    Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.

    Comment?

  19. MD Anderson Study Identifies Significant Cost Differences Between Breast Cancer Chemotherapy RegimensRead the original story

    Jun 4, 2016 | Newswise

    Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center . Understanding cost differences should help guide informed discussions between patients and physicians when considering chemotherapy options.

    Comment?

  20. Scientists Finally Understand How Invasive Breast Cancer Works: Is New Treatment Next?Read the original story

    Jun 4, 2016 | Medical Daily

    About one in eight women will develop breast cancer in their lifetime, and each year more than 40,400 U.S. women are expected to die from the disease. Despite many advances, the cancer remains a formidable enemy for patients and doctors alike; however, a team of researchers from the University of Zurich in Switzerland may have figured out how to kill a type of cancer cell that they've never been able to before.

    Comment?